Medical Devices industry deals in September 2021: GlobalData
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Medical Devices industry deals total $17.1bn globally in September 2021

26 Oct 2021

Total medical devices industry deals worth $17.1bn were announced globally for September 2021, with the $12.4bn acquisition of Hill-Rom Holdings being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 10.7% over the previous month of $15.42bn and a rise of 39.8% when compared with the last 12-month average of $12.21bn.

In terms of number of deals, the sector saw a drop of 23.70% with 132 deals in September 2021 when compared to the last 12-month average of 173 deals.

In value terms, North America led the activity with deals worth $16.07bn in September 2021.

medical devices industry deals in September 2021: Top deals

The top five deals accounted for 88.02% of the overall value during September 2021.

The combined value of the top five deals stood at $15.02bn, against the overall value of $17.1bn recorded for the month.

The top five medical devices industry deals of September 2021 tracked by GlobalData were:

1) Baxter International $12.4bn acquisition deal with Hill-Rom Holdings

2) The $1.45bn acquisition of BK Medical Systems by GE Healthcare

3) Zoll Medical $538m acquisition deal with Itamar Medical

4) The $336m acquisition of 84% stake in DeVoro Medical by Boston Scientific

5) Mesa Laboratories $300m acquisition deal with Agena Bioscience

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.